Wells Fargo & Company »

Aclaris Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $21k 20k 1.05
2023-09-30 $125k 18k 6.85
2023-06-30 $334k 32k 10.37
2022-12-31 $120k 7.6k 15.75
2022-09-30 $95k 6.1k 15.54
2022-06-30 $89k 6.3k 14.00
2022-03-31 $685k 40k 17.21
2021-12-31 $477k 33k 14.55
2021-09-30 $2.2M 121k 18.00
2021-06-30 $20k 1.1k 18.02
2021-03-31 $35k 1.4k 25.00
2020-12-31 $214k 33k 6.50
2020-09-30 $5.6k 1.2k 4.61
2020-06-30 $4.7k 2.2k 2.09
2020-03-31 $54k 52k 1.03
2019-12-31 $49k 26k 1.88
2019-09-30 $35k 32k 1.08
2019-06-30 $54k 25k 2.17
2019-03-31 $184k 31k 6.01
2018-12-31 $202k 27k 7.40
2018-09-30 $229k 16k 14.52
2018-06-30 $297k 15k 19.96
2018-03-31 $268k 15k 17.50
2017-12-31 $376k 15k 24.66
2017-06-30 $1.1M 41k 27.11
2017-03-31 $369k 12k 29.86
2016-12-31 $175k 6.5k 27.09
2016-09-30 $84k 3.3k 25.72
2016-06-30 $30k 1.6k 18.19
2016-03-31 $30k 1.9k 16.27
2015-12-31 $45k 1.7k 27.11